The intersection of gastrointestinal tract and dangerous factor, patient of

The intersection of gastrointestinal tract and dangerous factor, patient of arthritis, investigate that starts
It is reported ' Reporter Wang LeMin) On December 17, are cured patient's gastrointestinal risk factor of Chinese arthritis that the SCTE initiates by China and managed and promoted the project to start in Beijing. This project aims at understanding the high current situation of endangering the factor of patient's gastrointestinal tract of Chinese arthritis, improve the level that the medical worker especially the rheumatism dept. and medical worker of dept. of orthopedics carries on standardized management at the arthritis patient's treatment.

China cure the intersection of SCTE and the intersection of rheumatism and immune the intersection of branch and president, the intersection of BJ Union Hospital and the intersection of rheumatism and immune the intersection of head of the department and piece, doctor of training, present Professor with respect to speak spring, it is not that a steroid body resist antalgesic (NSAIDS) of inflammation that most arthritis patients need to take for a long time ,And it is one of the dangerous factors causing the serious gastrointestinal tract to react to use NSAIDS. In this kind of patient, more than 86% of person has gastrointestinal tract to endanger the factor high, because the digestive tract happen and damage the clinical symptom not obvious to most patients, once symptom appears, has often already amalgamated digestive tract ulcer, bleeding, punch or obstructing,etc.. But a troubling one is, at present no matter the doctor is still a patient, have insufficient understanding of this.

Shanghai Communications University medical college subsidiary Yan Chai Hospital Professor Bao ChunDe says, at present, quote the foreign research results about the high data which endanger the factor of patient's gastrointestinal tract of arthritis, our country has not launched this kind of investigation yet, but because of the ethnic group's difference, these data may not be suitable for a Chinese patient, so need launching this kind of and endangering the factor to investigate high to compatriot's patient badly.

It is reported, the investigation that this project will last 3 months to 5000 patients in the form of questionnaire investigation in hospital of 28 of the first, second and third of the whole country, it is estimated that will release the investigation result next July. This project is supported by Pfizer investment Co., Ltd..



The intersection of gastrointestinal tract and dangerous factor, patient of arthritis, investigate that starts